# US 2018/0023133 A1 · Systems and methods for epigenetic sequencing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023133 A1
- Document ID: US20180023133A1
- Status: Published application
- Kind: A1
- Application number: 15/670,929
- Filed: 2017-08-07
- Published: 2018-01-25
- Earliest claimed: 2012-03-05
- Assignees: President and Fellows of Harvard College; The General Hospital Corporation
- Applicants: President and Fellows of Harvard College; The General Hospital Corporation
- Inventors: Assaf Rotem; Oren Ram; Bradley E. Bernstein; David A. Weitz
- Web page: https://patentgrep.com/patent/US20180023133A1

## CPC

- C12Q 1/6869: Methods for sequencing
- B01F 33/3021: {the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets}
- B01L 3/502784: {specially adapted for droplet or plug flow, e.g. digital microfluidics}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01F: MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING (mixing paints B44D3/06)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

The present invention generally relates to microfluidics and/or epigenetic sequencing. In one set of embodiments, cells contained within a plurality of microfluidic droplets are lysed and the DNA (e.g., from nucleosomes) within the droplets are labeled, e.g., with adapters containing an identification sequence. The adapters may also contain other sequences, e.g., restriction sites, primer sites, etc., to assist with later analysis. After labeling with adapters, the DNA from the different cells may be combined and analyzed, e.g., to determine epigenetic information about the cells. For example, the DNA may be separated on the basis of certain modifications (e.g., methylation), and the DNA from the separated nucleosomes may be sequenced using techniques such as chromatin immunoprecipitation (“ChIP”). In some cases, the DNA sequences may also be aligned with genomes, e.g., to determine which portions of the genome were epigenetically modified, e.g., via methylation.

## Claims

### Claim at position 1

1-111. (canceled)

### Claim 112

A method comprising:
providing a solution comprising a plurality of nucleic acid sequences originating from a plurality of cells, at least some of the nucleic acid sequences being attached to an adapter, the adapter comprising an identification sequence, wherein sequences originating from the same cell contain identical identification sequences, and sequences originating from different cells contain different identification sequences; and sequencing at least some of the sequences.

### Claim 113 (depends on 112)

The method of claim 112, wherein the adapter comprises a restriction site.

### Claim 114 (depends on 112)

The method of claim 112, comprising cleaving the adapter at the restriction site.

### Claim 115 (depends on 112)

The method of claim 112, wherein the solution is contained within a droplet.

### Claim 116 (depends on 112)

The method of claim 112, wherein the plurality of nucleic acid sequences comprise DNA.

### Claim 117 (depends on 112)

The method of claim 112, wherein the plurality of nucleic acid sequences comprise RNA.

### Claim 118 (depends on 112)

The method of claim 112, wherein the primer site comprises a universal primer.

### Claim 119 (depends on 112)

The method of claim 112, wherein the primer site comprises a poly-T primer site.

### Claim 120 (depends on 112)

The method of claim 112, wherein the primer site comprises a random primer site.

### Claim 121 (depends on 112)

The method of claim 112, wherein the primer site comprises a PCR primer site.

### Claim 122 (depends on 112)

The method of claim 112, wherein the identification sequences comprise 8 nucleotides.

### Claim 123 (depends on 112)

The method of claim 112, wherein a plurality of adapters are used, comprising a plurality of different identification sequences each having the same length, and a substantially identical restriction site.

### Claim 124 (depends on 112)

The method of claim 112, further comprising aligning at least some of the sequenced sequences to a genome.

### Claim 125 (depends on 112)

The method of claim 112, wherein at least some of the cells arise from tissue.

### Claim 126 (depends on 112)

The method of claim 112, wherein sequences originating from the same cell contain identical identification sequences, and sequences originating from different cells contain different identification sequences.

### Claim 127 (depends on 112)

The method of claim 112, wherein the adapter is palindromic.

### Claim 128 (depends on 112)

The method of claim 112, further comprising aligning at least some of the sequenced nucleosome sequences to a genome.

### Claim 129 (depends on 112)

The method of claim 112, wherein unique barcodes or identification sequences are added to each droplet and added to the fragmented DNA sequences, providing an unique identifier for each individual cell.

### Claim 130 (depends on 112)

The method of claim 112, wherein RNA molecules are barcoded or ligated with an identification sequence using adaptors.

### Claim 131 (depends on 130)

The method of claim 130, wherein the adaptors are coupled to the RNA by direct ligation or by poly-T or random primer-based reverse transcription.

### Claim 132 (depends on 112)

The method of claim 112, wherein the adaptors are present on a solid support.

### Claim 133

A composition comprising:
a nucleic acid sequence comprising an identification sequence, a restriction site, an inversion of the restriction site and an inversion of the identification sequences.
